Apr 28 2020 |
Protecting Your Business from COVID-19 Class Action Lawsuits |
Foley & Lardner LLP |
Apr 28 2020 |
TCPA SCOTUS Briefing Complete!: Here’s Everything You Need to Prepare for the Big Oral Argument on May 6, 2020 |
Troutman Amin, LLP |
Apr 28 2020 |
SEC Proposes New Fair Value Rule 2a-5 |
K&L Gates LLP |
Apr 28 2020 |
Additional Guidance for Seasonal Employers Under the Paycheck Protection Program |
Wiggin and Dana LLP |
Apr 28 2020 |
EPA Publishes Draft Risk Evaluation of Perchloroethylene |
Bergeson & Campbell, P.C. |
Apr 28 2020 |
Zooming into New Privacy Issues |
Vedder Price |
Apr 28 2020 |
Supreme Court Harmonizes Circuit Courts: Willfulness Not a Prerequisite to Recovery of Defendant’s Profits in Lanham Act Cases . . . But It Can’t Hurt |
Greenberg Traurig, LLP |
Apr 28 2020 |
USCIS Releases Update to Employer I-9 Handbook |
Polsinelli PC |
Apr 28 2020 |
COVID-19 Government Enforcement And Investigation Priorities: Minimizing Your Business Risk |
Godfrey & Kahn S.C. |
Apr 28 2020 |
COVID-19: CMS Publishes Explanatory Guidance on Stark Blanket Waivers |
Foley & Lardner LLP |
Apr 28 2020 |
SEC Awards Whistleblower $18 Million Whose Reporting Resulted in Millions Returned to Retail Investors |
Kohn, Kohn & Colapinto |
Apr 28 2020 |
Managing And Mitigating The Risk Of Qui Tam Actions In The Wake Of COVID-19 |
Godfrey & Kahn S.C. |
Apr 28 2020 |
Amazon Faces Fire for Retaliation and Possible COVID-19 related OSHA Violations in New York |
Kohn, Kohn & Colapinto |
Apr 28 2020 |
Health Insurance for Motorcycle Riders |
Stark & Stark |
Apr 28 2020 |
Face or Fingerprint? The DEA Revisits Biometric Identifiers for e-Prescribing Controlled Substances |
Epstein Becker & Green, P.C. |
Apr 28 2020 |
Adjusting to Alice: USPTO’s View of Its Examination Guidelines |
Foley & Lardner LLP |
Apr 28 2020 |
NLRB: Employer Right to Take Unilateral Action Under a Collective-Bargaining Agreement Does Not Survive the Expiration of the Agreement Absent Explicit Language to the Contrary |
Hunton Andrews Kurth |
Apr 28 2020 |
COVID-19: Federal Stimulus Today, Federal Investigation Tomorrow: What TARP Can Tell Us about the Coming Wave of CARES Act Enforcement |
K&L Gates LLP |
Apr 28 2020 |
OIG Penalties Expand to Grant and Contract Fraud |
McDermott Will & Schulte LLP |
Apr 28 2020 |
SCOTUS: Clean Water Act Permits Required for Some Releases into Groundwater |
Beveridge & Diamond PC |
Apr 28 2020 |
Clear as Mud: What Does SCOTUS' "Functional Equivalent of a Direct Discharge" Standard Mean for the Future of Clean Water Act |
Jones Walker LLP |
Apr 28 2020 |
COVID-19: PPP Loans – Economic Need Determinations |
Pierce Atwood LLP |
Apr 28 2020 |
EEOC Provides Updated Guidance on COVID-19 Testing |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
Apr 28 2020 |
Update: Suspension of Trusted Traveler Enrollment Extended to June 1, 2020 |
Mintz |
Apr 28 2020 |
The Ever Thinning Right of Privacy at the Border—A Warning for Attorney Travelers. |
The National Law Review's Guest Contributors - NLR |
Apr 28 2020 |
COVID-19 UK Lockdown – a Time to Consolidate, Update and Innovate |
McDermott Will & Schulte LLP |
Apr 28 2020 |
Fund Adviser Receives $1 Million Penalty For Alleged Performance Misstatements in Private Fund Marketing Material |
Proskauer Rose LLP |
Apr 28 2020 |
CARES Act Update: IRS and Treasury Department Issue Guidance Under Code Section 163(j) |
Bracewell LLP |
Apr 28 2020 |
FTC Settles with Fashion Retailer for Record $9.3 Million for Alleged Mail Order Rule Violations |
Keller and Heckman LLP |
Apr 28 2020 |
State Tax Incentives, Clawbacks and COVID-19 |
McDermott Will & Schulte LLP |
Apr 28 2020 |
FTC’s Tips on Using Artificial Intelligence and Algorithms |
Jackson Lewis P.C. |
Apr 28 2020 |
Covid-19 Cyber Insurance: Do you have the right coverage? |
Foley & Lardner LLP |
Apr 28 2020 |
COVID-19 Likely Responsible for Hike in OSHA “Fatality/Catastrophe” Investigations at Healthcare Facilities |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
Apr 28 2020 |
Litigation Pacing During the Pandemic |
McDermott Will & Schulte LLP |
Apr 28 2020 |
FDA Issues Warning Letters to Companies Marketing CBD Products for Treatment of Disease and Addiction |
Keller and Heckman LLP |